Diaclone

Diaclone was founded in 1986 and is well-known for its expertise in the fields of inflammation, oncology, and immunology. The company provides top-tier monoclonal antibodies, high-quality ELISA and ELISpot reagents; it also offers antibody customization services based on hybridoma and phage display technologies, as well as kit development services for in vitro diagnostics, life science research, and the pharmaceutical industry.